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Purpose: Microbeam radiation therapy (MRT) is an experimental radiotherapy technique that has
shown potent antitumor effects with minimal damage to normal tissue in animal studies. This unique
form of radiation is currently only produced in a few large synchrotron accelerator research facilities
in the world. To promote widespread translational research on this promising treatment technology
we have proposed and are in the initial development stages of a compact MRT system that is based
on carbon nanotube field emission x-ray technology. We report on a Monte Carlo based feasibility
study of the compact MRT system design.
Methods: Monte Carlo calculations were performed using EGSnrc-based codes. The proposed small
animal research MRT device design includes carbon nanotube cathodes shaped to match the corre-
sponding MRT collimator apertures, a common reflection anode with filter, and a MRT collimator.
Each collimator aperture is sized to deliver a beam width ranging from 30 to 200 μm at 18.6 cm
source-to-axis distance. Design parameters studied with Monte Carlo include electron energy, cath-
ode design, anode angle, filtration, and collimator design. Calculations were performed for single and
multibeam configurations.
Results: Increasing the energy from 100 kVp to 160 kVp increased the photon fluence through the
collimator by a factor of 1.7. Both energies produced a largely uniform fluence along the long dimen-
sion of the microbeam, with 5% decreases in intensity near the edges. The isocentric dose rate for
160 kVp was calculated to be 700 Gy/min/A in the center of a 3 cm diameter target. Scatter contri-
butions resulting from collimator size were found to produce only small (<7%) changes in the dose
rate for field widths greater than 50 μm. Dose vs depth was weakly dependent on filtration material.
The peak-to-valley ratio varied from 10 to 100 as the separation between adjacent microbeams varies
from 150 to 1000 μm.
Conclusions: Monte Carlo simulations demonstrate that the proposed compact MRT system design
is capable of delivering a sufficient dose rate and peak-to-valley ratio for small animal MRT studies.
© 2012 American Association of Physicists in Medicine. [http://dx.doi.org/10.1118/1.4728220]
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I. INTRODUCTION
In recent decades, a revolution in radiotherapy technol-
ogy has significantly improved anatomical radiation target-
ing accuracy and radiation dose distribution optimization.1–4
Intensity-modulated radiotherapy and image-guided radio-
therapy are widely used and have been shown to produce
equal/better local tumor control with fewer treatment side
effects.5–7 However, the Holy Grail of eradicating tumor with-
out harming surrounding normal tissue still seems unap-
proachable for many types of cancer patients, especially those
with large tumors, ill-defined tumor volumes, and/or nearby
radiosensitive normal tissues, including many pediatric can-
cer patients.8 An ideal radiotherapy approach would need to
have intrinsic selectivity to tissue type—eradicating tumor
cells while leaving normal tissue function undamaged under
the same radiation. Microbeam radiation therapy (MRT) is an
experimental radiotherapy that has shown such tissue type se-
lectivity in animal studies.9–12 So far only a few synchrotron
facilities in the world are capable of generating the unique
spatial and temporal patterns of MRT radiation.13 Further,
the radiobiological mechanisms involved are still not well
understood.13 The lack of widely available MRT delivery sys-
tems hinders the progress of studies of the MRT mechanism
now and of clinical application in the future. Our multidis-
ciplinary research group has pioneered a compact MRT de-
vice using a nanotechnology-enabled x-ray tube technology.14
This compact MRT technology is currently in the early phase
of device development, testing, and feasibility demonstration.
In this paper, we report the progress of one aspect of the
technology development—Monte Carlo study of the proposed
compact MRT irradiation system.
I.A. Microbeam radiotherapy
MRT is distinctly different from all conventional forms
of radiotherapy in terms of its spatial dose distribution
pattern, total dose, and dose rate. Typical MRT treatments
deliver microscopically discrete spatial dose distributions:
10–100 μm wide parallel beams with a separation of several
hundred microns between adjacent beams. MRT treatments
generally consist of a single fraction, as opposed to the
5–30 fractions delivered in conventional radiotherapy and
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radiosurgery treatments. The maximum entrance dose for a
single fraction MRT treatment is in the range of 100–1000 Gy
delivered at a dose rate of 100s Gy/s. Although not well
known, MRT is not a new experimental radiotherapy
technique.15 A recent review paper by Brauer-Krisch et al.13
has summarized the history of MRT technology development
as well as developments in MRT radiobiology over the last
two decades. Preclinical studies using different animal models
have demonstrated that a single MRT treatment of hundreds
of Gy peak dose can preserve normal tissue function, in-
cluding that of the developing central nervous system.10, 13, 16
Separate animal studies have shown that the same MRT
radiation provided excellent tumor control.9, 10, 12, 17
There are two major obstacles in translating MRT from re-
search laboratories to clinical use: (1) the lack of comprehen-
sive understanding of the underlying radiobiological mech-
anism and (2) the lack of widely available MRT irradiation
systems. Currently, there are only a few MRT facilities in
the world, such as the European Synchrotron Research Fa-
cility in France and the National Synchrotron Light Source,
Brookhaven National Laboratory in the United States. No
human MRT system exists today, although ESRF is in the
process of developing such a system.18 Because synchrotron-
based MRT systems are massive in size and extremely costly,
most cancer research groups are prevented from performing
MRT research in their own laboratories, thus hindering the
advancement of MRT mechanistic research and its potential
clinical application.
I.B. Carbon nanotube field emission technology
Carbon nanotube (CNT) field emission is a new cathode
approach to x-ray tube technology that has been pioneered
by our nanomaterial research group.19, 20 Virtually all x ray
or electron beam generating machines today, such as x-ray
units, CT scanners, and medical linear accelerators rely on
thermionic emission cathodes, where electrons are “boiled”
off from a tungsten filament at very high temperatures. In
field emission, cathode electrons are generated not by heat
but by a quantum tunneling effect induced by the application
of an external electric field.19 The physics of field emission is
summarized by the Fowler-Nordheim equation (I = aV2exp
(−bφ3/2/βV)), stating that emission current (I) increases ex-
ponentially with increasing field voltage (V) for a substance
characterized by work function (φ), geometric enhancement
factor (β) and constants (a and b).19 Carbon nanotubes, due
to their atomic-scale sharp tips and large aspect ratios, have
a much larger field enhancement factor β and thus a much
lower emission threshold field that is practical to achieve in
compact devices (∼102 V/mm).
Compared to thermionic emission x-ray technology, field
emission x-ray technology is capable of higher temporal res-
olution. CNT field emission technology makes the design of
spatially distributed x-ray sources possible as CNT film cath-
odes can be in any form and shape, such as a segmented pixel
cathode array. Each of the cathode segment/pixel can be indi-
vidually programmable within the same x-ray tube.21–24
Our multidisciplinary research team has pioneered the
development of a number of novel imaging and irradiation
devices based on CNT field emission technology, including
micro-CT,25, 26 multipixel stationary breast tomosynthesis,27
multipixel stationary tomosynthesis for image-guided
radiotherapy,28 micro-CT-RT,22 and image-guided single
cell irradiation.23, 29 Based on the same nanotechnology, we
propose a novel compact MRT irradiation system.14
I.C. CNT-technology enabled MRT system
We are in the process of developing a prototype compact
MRT irradiation system and are conducting feasibility
studies and technology exploration. There are significant
technical differences between our proposed x-ray tube-based
MRT radiation technology and that studied in existing
synchrotron-based facilities. For instance, synchrotron MRT
has practically no beam divergence and exhibits dose rates
of 1000 Gy/s, which are unreachable by any x-ray tube
technology. So far there is no evidence suggesting that such
a high dose rate is biologically necessary for MRT. A theo-
retical study by Enzmann and Pelc indicated that dose rates
below 1000 Gy/s could result in a blurred dose distribution
in moving animal targets.30 Although we have no knowledge
on the degree of potential motion blur in future animal
irradiation, we have shown that CNT-based x-ray systems are
capable of at least 15 ms temporal-resolution gating that may
significantly minimize any motion blur.31–33 Additionally,
CNT cathode technology is capable of much higher electron
current densities compared to thermionic cathodes34 and
allows cathode shape to be customized according to need. For
the reasons mentioned above, CNT-based x-ray technology
is ideally suited for use in a compact MRT device. In the
initial phase of our research, we are exploring the technical
feasibility and constraints of this novel x-ray system. Monte
Carlo simulation is a valuable tool to assist many aspects of
the system design and, based on the radiation dosimetry it
would produce, to predict system performance.
I.D. Monte Carlo simulation study
Monte Carlo techniques have been widely used for clinical
and research radiation dosimetry studies including MRT
dosimetry. Nettelbeck et al.35 have studied the effect of
synchrotron-based beam and collimator parameters on dose
distribution and microbeam parameters using the Monte Carlo
simulation code PENELOPE.36 Prezado et al. have performed
PENELOPE calculations to evaluate optimal beam energy37
and collimator design38 for the ESRF MRT facility. Polar-
ization effects in synchrotron microbeams have been studied
using GEANT (Refs. 39 and 40) and EGS-based simulation
codes.41, 42 Siegbahn et al.43 have found good agreement
between PENELOPE microbeam calculations and Si-based
strip detectors as well as with other Monte Carlo simulation
codes. Monte Carlo simulation has also been successfully
used to study electron microbeam dosimetry. Our group has
successfully applied the Monte Carlo technique to assist in the
design of an electron microbeam cellular irradiation device23
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FIG. 1. Cartoon illustration of the proposed ring-design compact MRT system design. The design can scaled for small animal research and potential human
therapy application. (a) Illustration of the basic concept of the compact MRT device in clinical use. The linear circular x-ray microbeam source is located within
the circular x-ray tube housing. Power supplies, control electronics, and other supporting components of the MRT device are not shown. (b) A top view schematic
of a segmented ring configuration consists of 24 linear segment sources equally spaced within the ring. For better clarity only beams from selected linear source
segments are shown, emitting multiple planar microbeams as shown in (c). (c) A single linear segment anode, in which multiple parallel diverging microbeams
are produced. The simulation reported in this article included up to 30 parallel planar microbeams.
and a small-animal IMRT delivery system21 enabled by CNT
technology.
In this paper, we report the results of a Monte Carlo simula-
tion study evaluating the capabilities of the proposed compact
MRT device. These results have been used to provide design
guidance to the development of the prototype device.
II. METHODS AND MATERIALS
We have proposed a compact ring-shaped MRT system
where each microbeam is generated from a segmented circu-
lar array of x-ray sources that surrounds the treatment object
for small animal and potential human brain irradiation.14 The
basic design of a ring-shaped MRT system is illustrated in
Fig. 1. Figure 1(a) shows a conceptual drawing of a dis-
tributed x-ray source in a ring configuration around a human
patient’s head. The circular x-ray source consists of a num-
ber of linear x-ray source segments, each of which generates
microbeams irradiating the treatment object from a different
direction. The carbon nanotube field emission x-ray source
segments are individually addressable to differentially control
the beam intensity if needed. Figure 1(b) shows a top view of
multiple microbeams generated from selected linear source
segments. The microbeams overlap at a lesion located at the
center of the target. Each beam in Fig. 1(b) is a set of paral-
lel planar microbeams emerging from a single anode segment
as shown in Fig. 1(c). The MRT system relies on a circular
linearly distributed x-ray source design to generate high pho-
ton fluence in the treatment target at the center of the MRT
ring. Each of the microbeam planes is produced by generat-
ing electrons from a ring-shaped (or an array of linear seg-
ments) distributed CNT cathode, the electrons hitting a com-
mon reflection anode, and the resulting x-rays going through
a MRT beam collimation system. Adjacent microbeam planes
are generated the same way from additional arrays of linear
CNT cathode segments on the ring system.
The proposed MRT system design can be reduced into
many circular x-ray sources that each produces a single mi-
crobeam plane in the object at the center of the ring-shaped
system. Each of the circular MRT x-ray sources can be di-
vided further into many individual linear x-ray source seg-
ments arranged in a circle with the diameter of the MRT de-
vice. We start the simulation work with the basic unit of the
MRT design, the linear CNT x-ray source, and finish it with
the ring-shaped MRT system.
II.A. Basic CNT-MRT device design
The compact MRT device consists of parallel microbeam
generating x-ray source segments. The schematic of the MRT
segment used in this study is shown in Fig. 2. The segment
consists of the following parts: a CNT-based cathode, fo-
cusing electrodes (in the microbeam width direction only), a
tungsten anode, a vacuum chamber exit window, and an MRT
collimator. In the prototype design studied in this project, the
cathode, anode, and support devices are placed in a hexagonal
vacuum chamber. The cathode is sized such that the projec-
tion of the electron beam on the anode matches the collimator
size in both dimensions. The collimator opening is designed
to produce a microbeam of 100 μm in width and 5–30 mm
in length. A 200-μm thick steel exit window sits 4.5 cm from
the center of the electron beam as it hits the anode. A 10 cm
thick collimator is placed 5 mm outside of the vacuum cham-
ber. While a much thinner collimator would be adequate for
beam attenuation (a monoenergetic 160 keV beam has a TVL
of 1.1 cm in copper), 10 cm thickness is necessary to prevent
cross talk between adjacent microbeams.
The vacuum chamber and collimator thicknesses define
a minimum source-to-surface distance (SSD) of 15 cm. The
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FIG. 2. Geometry of prototype single-direction microbeam MRT compo-
nent used in Monte Carlo simulations. The 80-μm collimator aperture is not
drawn to scale.
intention is to use this device for treatments at a constant
source-to-axis distance (SAD). The minimum SAD for a
3 cm diameter mouse is therefore 16.5 cm. To allow some
flexibility in the location of isocenter within the mouse
model, the SAD was defined to be 18.5 cm.
The physical design of the prototype device requires a dis-
tance from the anode to the exit window no less than 4.5 cm,
and a SSD to the target surface no less than 17.5 cm. The
maximum anode voltage of the prototype device is 160 kVp.
II.B. Monte Carlo simulation
Radiation transport calculations in this work were carried
out using EGSnrc-based Monte Carlo codes.44 The EGSnrc
code is the latest in a line of electromagnetic radiation trans-
port simulations used in high-energy, nuclear, and medical
physics, and contains many improvements over earlier ver-
sions (EGS4) that improve the accuracy of radiation trans-
port down to 1 keV.44 In particular, the 2009 release used
in this project allowed some single-particle electron track-
ing, whereas previous versions of EGS used the continuous
beam slowing model (CBSM), in which only aggregate ef-
fects of electron beams are used. This improves the accuracy
of the dose calculations at the μm-level length scales nec-
essary for studying microbeams. Calculations in the all por-
tions of the x-ray device, including electron beam, anode,
exit window, and collimator were performed using BEAMnrc,
an EGSnrc-based radiotherapy simulation package. Dosime-
try calculations were performed using the companion package
DOSXYZnrc. Simulation parameters used for all calculations
are shown in Table I.
The Monte Carlo simulations in this work are focused on
direct calculation of a single plane microbeam and its dose de-
position in the target. A superposition of multiple microbeam
TABLE I. Summary of EGSnrc parameters used in the simulation of the







Boundary crossing algorithm PRESTA-I
Skin depth for BCA 0
Electron-step algorithm PRESTA-II
Spin effects On
Bremsstrahlung angular sampling Koch and Motz
Bremsstrahlung cross sections NIST
Bound Compton scattering On
Pair angular sampling Simple
Photoelectric angular sampling On
Raleigh scattering On
Atomic relaxations On
Electron impact ionization On
planes from different directions was used to study the dosi-
metric properties of the microbeam ring design. The simu-
lation begins with a normal-incidence electron beam striking
the tungsten anode as shown in Fig. 2. Two variance reduction
techniques were used: directional bremsstrahlung splitting
and selectively changing the electron cut-off energy. Direc-
tional bremsstrahlung splitting enhances the photon produc-
tion calculation efficiency by repeating single bremsstrahlung
events multiple times. The resulting photons are then weight
adjusted and projected into a user-defined field.45 The elec-
tron cut-off energy (ECUT) was set to 50 keV in the filter and
collimator material to save calculation time by not tracking
low-energy electrons outside the anode. The inclusion of the
high-energy cutoff outside the anode produced no discernable
difference in dose or fluence results.
Dose rate calculations were performed by simulating a
cylindrical water phantom in DOSXYZnrc. The phantom was
configured as a cylinder having a diameter and thickness of
3 cm (the diameter of an average mouse), with the calculated
dose rate averaged over a voxel 1 mm × 1 mm × 10 μm in
the central region of the microbeam. The particles produced
by the BEAMnrc MRT device simulation were tallied as
they exited the collimator and recorded in a phase space
file containing each particle’s type, energy, position, and
direction. This phase space file was used to calculate 3D dose
distributions in the water phantom and the mouse model.
Phase space particles were recycled up to 20 times for each
3D dose calculation. These simulations were performed using
DOSXYZnrc. Dose rate results were calculated in terms of
cGy/incident electron and were renormalized to cGy/min/mA.
All dose rate calculations assume dc emission current. Voxel
dimensions varied depending on what property was being
examined, but were typically 5 μm along the short dimension
of the microbeam, 500 μm along the long dimension, and
1 mm in depth. All calculations were performed to a statistical
uncertainty of 0.5% or better in the high-dose regions.
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II.C. MRT system parameters studied
We performed MC simulation calculations for each of the
major components of the compact MRT system including the
cathode, anode, filter, collimator, and irradiation phantom in
terms of material, geometry, x-ray beam energy, dose rate, and
MRT-specific dose distribution.
II.C.1. Cathode
The cathode is modeled as a normal-incidence paral-
lel rectangular beam impinging perpendicularly to the an-
ode surface. Normal incidence is required for multiple beam
operation. The electron beam size is selected to match
the projection of the collimator on the anode surface.
A larger cathode would produce photons unable to pass
through the collimator opening. A smaller cathode would pos-
sibly produce a more uniform beam,21 but would require an
increased current density to achieve the same MRT photon
fluence and would therefore require additional anode cooling
for the same current. Electron focusing electrodes are used to
focus the electron beam to a width of 1–2 mm before strik-
ing the anode. The effective microbeam source width after
a 5◦–20◦ anode angle is ∼100–200 μm. The electron beam
energies studied were 100 kV and 160 kV. The Monte Carlo
calculations in this study do not model the transport of the
electron beam through the focusing electrodes, but begin with
the electrons incident on the anode surface.
II.C.2. Anode
The anode angle was varied from 5◦ to 25◦ with respect to
the central axis of the resulting x-ray beam. For a given pho-
ton beam size a smaller anode angle can increase the dose rate
by using a larger electron spot size on the anode. But this can
force photons to traverse a greater thickness of tungsten be-
fore leaving the anode, thus reducing the dose rate. The Monte
Carlo results for angle selection were analyzed for their effect
on beam symmetry and dose rate.
II.C.3. Exit window and collimator
X-ray sources typically use thin filters to remove low-
energy x rays from the beam. The MRT x-ray tube vacuum
chamber exit window also acts as a filter. The filter mate-
rial and thickness options of 2 mm aluminum and 200- and
400-μm steel were studied.
The MRT collimator is designed to project a large ratio
(small width and large length) microbeam at isocenter. Ex-
cept where stated, simulations assumed a single-aperture col-
limator. Field size in the long dimension was defined to be
5–30 mm, with the narrow dimension varying from 50 to
200 μm at isocenter. Collimator openings are nondivergent.
Multiple parallel microbeam configuration results are gener-
ated based on single microbeam simulation results.
There are two considerations in collimator thickness de-
sign: preventing cross talk between adjacent microbeams,
and providing sufficient attenuation between adjacent beams.
Cross talk can be minimized by having a large aspect ratio be-
tween collimator thickness and aperture width, and by placing
the upstream edge of the collimator as close to the radiation
source as possible. The physical design of the vacuum cham-
ber in the prototype device requires the collimator be placed
outside the chamber, at least 5 cm from the radiation source.
Under these circumstances, the collimator thickness required
to prevent cross talk is much thicker than necessary for atten-
uation purposes. The collimator material used in all calcula-
tions is copper.
II.C.4. Dose calculations in the phantom
All dose calculations were performed in a 3 cm diame-
ter cylindrical water target centered 18.5 cm from the photon
source. The variations in device components described above
(including beam energy, anode angle, exit window material,
and collimator geometry) were evaluated for their effect on
dose rate, peak-to-valley ratio for adjacent beams, and beam
divergence. Dose rate was evaluated at the phantom surface
and at depth (isocenter).
III. RESULTS
III.A. Anode
Dose rate at the center of the microbeam vs anode angle
is shown in Fig. 3. The dose rate is shown to be relatively
constant between 10◦ and 25◦. Below 10◦, the dose rate be-
gins dropping by more than 10%. Electron spot sizes on the
anode are scaled such that the projection of the electron spot
matches the collimator aperture. Current density on the anode
surface, and hence the spontaneous anode heating, is therefore
minimized for the smallest possible anode angle. Final dose
calculations were performed assuming a 10◦ anode angle. No
discernable heel effect through the collimator was observed
for this anode angle as shown in Fig. 4(a). This is likely due
to electron scatter blurring out any heel effect over the very
narrow width of the collimator opening.




















FIG. 3. Microbeam peak dose rate vs angle for 150-kVp configuration. The
single direction microbeam width is 100 μm.
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FIG. 4. Fluence distribution of photons emerging from MRT collimator for 10◦ anode angle. (a) The fluence distribution in the narrow dimension for an
80.6-μm wide collimator projecting to a 100-μm wide microbeam at isocenter. (b) The fluence in the long dimension for an 8.1 cm long extended collimator
projecting to 10 cm at isocenter. The length of the microbeam can be defined by the length of the collimator aperture.
III.B. Exit window and collimator
Percentage depth dose (PDD) curves for the three different
beam filtrations are shown in Fig. 5. The filter options were
2 mm Al, 200 μm Fe, and 400 μm Fe. Insufficient beam filtra-
tion would lead to excessive surface dose. The 200-μm steel
exit window of the vacuum chamber produces similar beam
hardness to the 2 mm aluminum filter at depth but has 10%
less surface dose. Increasing the thickness of the steel exit
window from 200 μm to 400 μm further reduces the surface
dose.
Figure 4(a) shows negligible beam transmission through
the copper collimator, indicating that the 10 cm thick-
ness is sufficient to attenuate the x-ray beam. Small an-
gle scattering near the edge of the collimator aperture may
reduce the average beam energy, increasing surface dose
and reducing the penetrating power of the beam. Figure 6
demonstrates that the energy spectrum of the x-rays do not



















FIG. 5. Microbeam percentage depth dose of the MRT in the cylindrical
water target for three different filtration thickness/materials.
substantially change as they pass through the microbeam
collimator.
III.C. Dose distribution
For the 160-kVp configuration, the depth dose curve is
shown in Fig. 5. Dose at isocenter can be estimated to be
60% of the dose at the surface. The lateral dose profile at
1.5 cm depth for a 100-μm wide microbeam is shown in
Fig. 7. The dose profile is characterized by relatively sharp
field edges and very low dose outside the field. When a mul-
tiple microbeam array is used for irradiation, the dose in the
valley is the cumulative phantom scatter dose from each of
the microbeams (Fig. 8). For a microbeam array that covers a
1 cm width perpendicular to the microbeams, the peak-to-
valley ratio ranges from 10 to 100 as beam spacing varies
from 150 to 500 μm for a microbeam width of 100 μm
FWHM (Fig. 9).






















FIG. 6. Energy spectrum of a 150 kV beam before and after passing through
the copper collimator. The narrow peak is a characteristic x-ray peak from
the tungsten anode.
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FIG. 7. Log-linear plot of the dose profile of a 160-kVp microbeam at
1.5 cm depth in a water target. The beam is collimated to form a 100-μm
wide beam (FWHM) at 1.5 cm depth.
Figure 10 shows the microbeam dose profile variation at
beam attenuating depths of 5 mm, 15 mm, and 25 mm in a
30 mm diameter phantom. The corresponding microbeam
width varied from 100 μm at depth of 5 mm to 120 μm at
the depth 25 mm.
III.D. Dose rate
The dose rate varies with electron beam energy (E) ac-
cording to the standard E2 dependence of the bremsstrahlung
equation. The dose at the center of the 3 cm diameter phan-
tom for the 160 kV beam was calculated to be 1.9e-18 Gy
per incident electron for a 100-μm microbeam generated by
a 0.464 × 4 mm cathode. This corresponds to a dose rate of
700 Gy/A/min. This dose rate varies very little with collima-


















FIG. 8. Dose profile from multiple parallel 160 kV microbeams of 100-μm
width at depth of 15 mm. The distribution covers 1 cm with 33 microbeams
spaced 300 μm apart.


























FIG. 9. Peak-to-valley ratio for a single direction microbeam array irradiat-
ing a 1 cm tumor at different separation distances between adjacent beams
(pitch) as shown in Fig. 8.
tor width (Fig. 11), indicating that photon scatter contributes
relatively little to dose.
III.E. Ring design
The simulation results reported above describe single or
parallel planar microbeams emerging from the same anode
segment and entering the target from the same angle. We have
simulated the dosimetry of the ring-design MRT shown in
Fig. 1 using multiple instances of the single-direction mi-
crobeam simulation results at regular angle spacing. This ring
design substantially increases the dose rate in the tumor, and
the total dose in the tumor region relative to adjacent areas.
The dose distribution obtained using a MRT ring design varies
with number of beams chosen. Figure 12 shows the dose





















FIG. 10. Microbeam dose profiles at beam attenuating depths of 5 mm,
15 mm (phantom center), and 25 mm. The microbeam energy is 160 kV and
the dose profile is simulated in a mouse phantom of 3 cm diameter.
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FIG. 11. Microbeam peak dose rate vs collimator (beam) width for the
160 kV single direction microbeam configuration. The dose rate for colli-
mators 100 μm or larger is approximately constant within the statistical un-
certainty.
distribution within the microbeam plane from the ring-design
for 12 and 24 regularly spaced microbeam sources.
IV. DISCUSSION
We anticipate that future CNT MRT systems will be capa-
ble of energies higher than 160 kVp, but will likely still be
lower energy that used at ESRF, which produces microbeam
energies having mean and peak values of 100 and 500 keV,
respectively.37 One consequence of lower energy is a greater
sensitivity to tissue inhomogeneities. For diagnostic-range
photon energies, dose absorption in bone is enhanced rela-
tive to absorption in tissue due to increased photoelectric ef-
fect interactions, which is strongly dependent on the effective
atomic number of the material. The degree of enhancement
can be as high as a factor of four, as shown in our previous
studies of similar devices.21 This effect will be somewhat mit-
igated by the large number of beams from different entry di-
rections utilized in the ring configuration. This is supported by
recent work by Chow et al. which demonstrated that arc con-
figurations for 100 kVp and 225 kVp beams lead to large dose
differences in bone, but minimal differences at isocenter.46
A second consequence of lower average energy is a steeper
depth dose curve. For a single beam, this can lead to a higher
entrance dose relative to the dose received by a tumor located
deep within the target. As shown in Fig. 5, the single direction
microbeam entrance dose can be 80% higher than the pre-
scribed tumor dose. While potentially problematic for single-
beam configurations, this effect is strongly mitigated by the
use of multiple beams surrounding the target in a ring config-
uration. As shown in Fig. 12(b), the entrance dose for a 24-
beam configuration can be less than 10% of the dose received
by the tumor.
The proximity of the radiation source (anode) to the treat-
ment target implies that microbeam divergence could be sig-
nificant across the depth of the target. Normalized dose pro-
files vs depth from a single direction microbeam are shown
in Fig. 10. For the physical constraints of the prototype sys-
tem (17 cm SSD, 3 cm diameter target), the maximum in-
crease of beam size due to divergence is 20 μm for a 100-μm
isocentric beam width. This value is much smaller than the
proposed separation (300 μm) between adjacent microbeams.
The divergence effect is further minimized in the proposed
ring configuration, in which each of the microbeams overlaps
with an opposing beam. The overlap of a microbeam with
other microbeams that have widened due to the divergence
effect could conceivably lead to the ring configuration ex-
hibiting microbeam widths larger than would be found from a
FIG. 12. Dose distributions within a microbeam plane for the ring-shaped source MRT design for 12 (left) and 24 (right) microbeam-direction configurations.
Each microbeam is conformal in the long dimension of the beam to a 5 mm tumor at the center of a 30 mm diameter cylindrical target. The dose distributions
displayed are within the plane of one of the microbeams. Dose profiles perpendicular to the microbeam plane are shown in Fig. 8.
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single direction microbeam, as shown in Fig. 10. This effect is
strongly mitigated, however, by the rapid dose falloff through
the target of the opposing beam, leading to only a negligible
increase in the cumulative microbeam width outside the cen-
ter of the overlap region, where the intensities of opposing
beams are comparable. The only observable impact of this ef-
fect is a small increase in the penumbra region in the center of
the target, where all beams overlap. The small impact of this
effect is included in the dose profiles and peak-to-valley ra-
tios shown in Figs. 8 and 9. While the geometric effect of this
divergence only weakly affects the peak-to-valley ratio, the
biological effect of the beam widening is unclear. Previous
studies47 have suggested that the dose structure in the transi-
tion zone (on or near the penumbra of a single beam) may be
important.
Finally, our study shows that the dose rate from a single
4 mm linear CNT cathode segment in the proposed compact
MRT system is ∼700 Gy/A/min. Target heating considera-
tions are expected to limit the anode current to ∼1 A per
source segment for our prototype MRT tube design, leading to
a theoretical dose rate limit of 700 Gy/min per segment source
at isocenter. A 24-source ring configuration would therefore
lead to an isocentric dose rate of 16 800 Gy/min or 280 Gy/s.
For a typical MRT treatment dose of several hundreds Gy, the
treatment delivery time would be a few seconds. This dose
rate, while much higher than those used in conventional ra-
diotherapy, is considerably below the 15 000 Gy/s reported at
ESRF.37 While the radiobiological impact of the MRT dose
rate is still not well understood, the longer exposure times re-
quired by this device does raise the possibility of organ move-
ment during beam delivery. If not managed, this effect could
lead to an effective increase in beam width and valley dose
and decrease in peak dose. Cao et al. have demonstrated that it
is possible to eliminate the impact of cardiac motion in imag-
ing the heart of a free breathing mouse during a 44 min session
by respiratory and cardiac gating using a CNT field emission
x-ray device.31 We plan to use a similar gating technique for
CNT-based MRT irradiation when organ motion is of concern.
V. CONCLUSIONS
The Monte Carlo study demonstrates that it is feasible
for the compact carbon nanotube field emission-based MRT
device to produce planar microbeams with some of the dosi-
metric features similar to those generated by synchrotron fa-
cilities. However, several differences between the proposed
compact MRT device and the synchrotron-based MRT re-
main. These differences include energy spectrum, beam di-
vergence, and dose rate. It remains to be investigated if these
distinctions would lead to differences in any radiobiological
endpoints. The estimated treatment delivery time of our com-
pact MRT system design is several seconds for several hun-
dred Gy of peak dose, compared to synchrotron-based MRT
systems for which the delivery time can be a small fraction of
a second. If necessary, we will rely on the demonstrated high
temporal-resolution cardiac gating for MRT treatment deliv-
ery to minimize the potential motion-induced MRT dosimetry
deterioration.
We have shown that the proposed compact MRT system
design is capable of MRT dosimetry similar to that of the syn-
chrotron based MRT for beam width of 100 μm in terms of
dose distribution and peak-to-valley ratio. The proposed com-
pact nanotechnology-enabled MRT system is not intended as
a prototype for clinical use, but has the potential to greatly
accelerate microbeam radiotherapy research by making the
MRT treatment delivery technology for animal studies read-
ily available to research laboratories outside the synchrotron
facilities. MRT development for animal studies, if successful,
may lead to the development of a system for clinical use.
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